Priya Hariharan

Priya Hariharan, Ph.D., serves as a Senior Research Scientist and Project Lead at Intas Pharmaceuticals since May 2021, focusing on cell therapy approaches for genetic disorders. Previously, Priya held roles at the National Institute of Immunohaematology from November 2015 to April 2021, including Scientist B and Research Associate, where work involved real-time quantification of telomere length and telomerase activity, along with flow cytometric analysis. The academic foundation includes a Ph.D. obtained from the National Institute of Immunohaematology in 2019, with prior research experience as a Junior Research Fellow and Summer Intern, where expertise in various molecular techniques and phytochemical isolation was developed. Additionally, Priya is currently engaged as an Industrial Postdoctoral Fellow at Intas Biopharmaceuticals, specializing in Cell and Gene Therapy.